Evidence map›Paper›PMID 25617357›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes.

Giselle Barreto-Torres, Jessica Soto Hernandez, Sehwan Jang, Adlín R Rodríguez-Muñoz, Carlos A Torres-Ramos, Alexei G Basnakian, Sabzali Javadov

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Anomalous AMPK-regulated angiotensin ATJournal of biomedical science · 2020
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Giselle Barreto-TorresDepartment of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico; and.
Jessica Soto HernandezDepartment of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico; and.
Sehwan JangDepartment of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico; and.
Adlín R Rodríguez-MuñozDepartment of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico; and.
Carlos A Torres-RamosDepartment of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico; and.
Alexei G BasnakianDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Sabzali JavadovDepartment of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico; and sabzali.javadov@upr.edu.
University of Puerto Rico System · PRUniversity of Arkansas for Medical Sciences · US

Funding

RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
The Role of Sensory Input to Mammalian Locomotion After the Loss of supraspinal.P20GM103642 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LASALDE-DOMINICCI, JOSE ANTONIO · 2013 to 2023
$20.6M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart FSC1HL118669 · NHLBI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI JAVADOV, SABZALI · 2012 to 2016
$1.3M
Nuclease mechanisms in acute kidney injuryI01BX002425 · VA · CENTRAL ARKANSAS VETERANS HLTHCARE SYS · PI Alexei G Basnakian · 2015 to 2026
–
BLRD VA I01 BX002425NHLBI NIH HHS SC1 HL118669NHLBI NIH HHS SC1HL118669NIGMS NIH HHS P20 GM103642NIGMS NIH HHS R25 GM061838NIGMS NIH HHS R25GM061838NIMHD NIH HHS G12 MD007600NIMHD NIH HHS G12MD007600
6 · The paper itself

Abstract

AMP kinase (AMPK) plays an important role in the regulation of energy metabolism in cardiac cells. Furthermore, activation of AMPK protects the heart from myocardial infarction and heart failure. The present study examines whether or not AMPK affects the peroxisome proliferator-activated receptor-α (PPARα)/mitochondria pathway in response to acute oxidative stress in cultured cardiomyocytes. Cultured H9c2 rat embryonic cardioblasts were exposed to H2O2-induced acute oxidative stress in the presence or absence of metformin, compound C (AMPK inhibitor), GW6471 (PPARα inhibitor), or A-769662 (AMPK activator). Results showed that AMPK activation by metformin reverted oxidative stress-induced inactivation of AMPK and prevented oxidative stress-induced cell death. In addition, metformin attenuated reactive oxygen species generation and depolarization of the inner mitochondrial membrane. The antioxidative effects of metformin were associated with the prevention of mitochondrial DNA damage in cardiomyocytes. Coimmunoprecipitation studies revealed that metformin abolished oxidative stress-induced physical interactions between PPARα and cyclophilin D (CypD), and the abolishment of these interactions was associated with inhibition of permeability transition pore formation. The beneficial effects of metformin were not due to acetylation or phosphorylation of PPARα in response to oxidative stress. In conclusion, this study demonstrates that the protective effects of metformin-induced AMPK activation against oxidative stress converge on mitochondria and are mediated, at least in part, through the dissociation of PPARα-CypD interactions, independent of phosphorylation and acetylation of PPARα and CypD.

Indexed as

Adenylate KinaseAnimalsAntioxidantsBiphenyl CompoundsCell DeathCell LineCyclophilinsDose-Response Relationship, DrugEnzyme ActivationEnzyme ActivatorsMembrane Potential, MitochondrialMetforminMitochondria, HeartMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMyocytes, Cardiac4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrileAdenylate KinaseAntioxidantsBiphenyl CompoundsCyclophilinsEnzyme ActivatorsMetforminMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreOxidantsPeptidyl-Prolyl Isomerase DPPAR alphaPpid protein, ratProtein Kinase InhibitorsPyronesReactive Oxygen SpeciesThiophenesAMPKH9c2 cardiomyocytesmetforminmitochondriaoxidative stressPPARα

Identifiers

PMID25617357
PMCPMC4385997
OpenAlexW2040281422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.